We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$578B
AUM Growth
+$59.6B
Cap. Flow
+$35.2B
Cap. Flow %
6.08%
Top 10 Hldgs %
31.21%
Holding
15,826
New
1,745
Increased
6,428
Reduced
6,082
Closed
1,423

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$830M
2
UNH icon
UnitedHealth
UNH
+$769M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$691M
4
AMZN icon
Amazon
AMZN
+$654M
5
BAC icon
Bank of America
BAC
+$634M

Sector Composition

Rank Sector Weight
1 Healthcare 3.13%
2 Technology 2.97%
3 Financials 2.19%
4 Consumer Discretionary 2.09%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUUDW
14101
DELISTED
Auddia Inc Warrants
AUUDW
$1.86K ﹤0.01%
74,592
+387
+0.5% +$11
ELEV
14102
PUT
DELISTED
Elevation Oncology
ELEV
$1.86K ﹤0.01%
3,300
-24,300
-88% -$14.3K
FCUV icon
14103
Focus Universal
FCUV
$3.96M
$1.85K ﹤0.01%
13
-143
-92% -$14.6K
HYPR icon
14104
CALL
Hyperfine
HYPR
$97M
$1.85K ﹤0.01%
2,100
+1,000
+91% +$962
THCH icon
14105
CALL
TH International
THCH
$51.3M
$1.85K ﹤0.01%
+520
New +$1.97K
SVRA icon
14106
PUT
Savara
SVRA
$1.08B
$1.84K ﹤0.01%
600
-11,700
-95% -$40.8K
MGTX icon
14107
CALL
MeiraGTx Holdings
MGTX
$1.22B
$1.83K ﹤0.01%
300
-18,900
-98% -$111K
KZR
14108
CALL
DELISTED
Kezar Life Sciences
KZR
$1.81K ﹤0.01%
270
-1,110
-80% -$8.27K
INSE icon
14109
CALL
Inspired Entertainment
INSE
$165M
$1.81K ﹤0.01%
200
-23,300
-99% -$221K
MAPS
14110
PUT
DELISTED
WM TECHNOLOGY INC A
MAPS
$1.79K ﹤0.01%
1,300
-4,800
-79% -$5.16K
ATXS
14111
PUT
DELISTED
Astria Therapeutics
ATXS
$1.79K ﹤0.01%
200
-3,100
-94% -$32.9K
NRC icon
14112
PUT
NRC Health Common Stock
NRC
$474M
$1.76K ﹤0.01%
100
-200
-67% -$3.79K
ACHV icon
14113
PUT
Achieve Life Sciences
ACHV
$759M
$1.76K ﹤0.01%
500
-3,200
-86% -$14.5K
DFLIW icon
14114
Dragonfly Energy Holdings Warrant
DFLIW
$32.4K
$1.71K ﹤0.01%
60,324
-269
-0.4% -$6
SXTPW icon
14115
60 Degrees Pharmaceuticals Warrant
SXTPW
$48.5K
$1.71K ﹤0.01%
47,675
+1,402
+3% +$41
RGP icon
14116
CALL
Resources Connection
RGP
$146M
$1.71K ﹤0.01%
200
-1,400
-88% -$11.8K
CLNN icon
14117
CALL
Clene
CLNN
$52.9M
$1.7K ﹤0.01%
+320
New +$1.61K
BRSP
14118
CALL
BrightSpire Capital
BRSP
$636M
$1.69K ﹤0.01%
300
-300
-50% -$1.77K
FCF icon
14119
PUT
First Commonwealth Financial
FCF
$2.19B
$1.69K ﹤0.01%
100
-4,600
-98% -$81.3K
IDN icon
14120
PUT
Intellicheck
IDN
$55.7M
$1.68K ﹤0.01%
600
-500
-45% -$1.26K
KTCC icon
14121
CALL
Key Tronic
KTCC
$42.6M
$1.67K ﹤0.01%
400
-1,600
-80% -$8.68K
EVC icon
14122
CALL
Entravision Communication
EVC
$825M
$1.65K ﹤0.01%
700
+400
+133% +$936
CCO icon
14123
PUT
Clear Channel Outdoor Holdings
CCO
$1.19B
$1.64K ﹤0.01%
+1,200
New +$1.83K
MMVWW
14124
DELISTED
MultiMetaVerse Holdings Limited Warrant
MMVWW
$1.64K ﹤0.01%
67,922
-60,758
-47% -$2.05K
CYTHW
14125
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
$1.64K ﹤0.01%
11,693
+100
+0.9% +$16

Similar funds

Citadel Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.

  • Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
  • Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
  • Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
  • Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
  • Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.